Original Contributions |
From the Georgetown University Medical Center, Department of Surgery, Washington, DC.
| Abstract |
|---|
|
|
|---|
3 expression was significantly increased (41±2.9%)
by high-flow conditions compared with low-flow. The changes in
G-protein expression were associated with a significant increase in
endothelial nitric oxide synthase (eNOS) activity,
elevated prostacyclin levels in the perfusing media, increased
pertussis toxincatalyzed ADP ribosylation of Gi
substrates, and
enhanced agonist-stimulated GTPase activity in cocultured ECs. In
contrast, high flow induced a significant decrease in
Gi
12 expression (57±5%) in SMCs cocultured with ECs,
an effect that was endothelium dependent, inhibited by
indomethacin, and correlated with a decrease in
pertussis toxincatalyzed ADP ribosylation of Gi
substrates,
reduced agonist-stimulated GTPase activity, and enhanced basal and
G-proteinstimulated adenylyl cyclase activity. These data demonstrate
that flow mediates selective changes in EC and SMC G-protein expression
concomitant with changes in G-protein functionality and cellular
signaling capacity. Moreover, flow-induced changes in SMC G-protein
signaling capacity are endothelium dependent and
require a cyclooxygenase product. G-protein
modulation may thus represent an important mechanism whereby
hemodynamic forces regulate vessel wall function.
Key Words: shear stress flow vascular endothelial cells vascular smooth muscle G-proteins
| Introduction |
|---|
|
|
|---|
In a similar manner to shear stress, ECs are exposed to cyclic strain that results from the pulsatile flow of blood. Cyclic strain increases the expression of endothelial substances including NO8 and cell adhesion molecule expression that may contribute to endothelial adhesion of monocytes on local vascular walls in vivo.9 Both tissue plasminogen activator and plasminogen activator inhibitor are enhanced after exposure of ECs to cyclic strain, with reactive oxygen species implicated in these processes.10 Cyclic strain also results in significant changes in EC signaling; namely, cAMP production,11 12 inositol triphosphate formation, diacylglycerol,13 and fibronectin production,14 all of which may contribute to the adaptation of the vasculature and in particular the endothelium, to changes in intravascular pressure. Vascular SMCs are also subjected to cyclic strain or stretch that results from the pulsatile flow of blood. Changes in SMC matrix/integrin interactions after cyclic strain have been demonstrated.15
Heterotrimeric G-proteins function as transducers of signals across the
cell membrane by coupling diverse receptors to effectors and thus play
a central role in signal transduction and cell
biology.16 17 By definition, they consist of
,
ß, and
subunits, each the product of distinct genes.
-Subunits bind and hydrolyze GTP and most obviously regulate the
activity of the most studied effector responses. Distinct subclasses of
-subunits involved in signal transduction include Gi
, G
q, and
Gs
.16 17 Recent evidence suggests that
inhibitory G-proteins (Gi
1,2,3)
and G
q may play a role in both agonist- and shear stressinduced
activation of NOS and COX-1, the enzymes responsible for the formation
of NO and prostanoids, respectively, in
ECs.18 19 20 Stimulation of these G-proteins
triggers a number of signal-transduction cascades, including activation
of K+ channels, phospholipase C, phospholipase
A2, and adenylyl
cyclase.16 17 21 22 Few studies have investigated
the possibility of flow-mediated regulation of vascular cell G-protein
expression, which may play an important role in vessel adaptation to
blood flow. To address this question, we used a perfused
transcapillary coculture system, previously developed in
our laboratory, which permits the chronic exposure of ECs and SMCs to
graded changes in pulsatile flow within the range of
physiological shear
stresses.23 We report here that increased flow
mediates selective and cell-specific alterations in vascular cell
G-protein expression that correlate with changes in cell-signaling
capacity and G-protein functionality.
| Methods |
|---|
|
|
|---|
12 and
Gi
3 were purchased from New England Nuclear.
Antisera against Gs
and G
q were purchased from Santa Cruz
Biotechnology, Inc. Anti-rabbit IgG (horseradish peroxidase linked) and
ECL detection system were obtained from Amersham.
[
-32P]ATP (800 Ci/mmol),
[32P]NAD (800 Ci/mmol), and
[
32P]GTP (30 Ci/mmol) were obtained from New
England Nuclear. L-NAME, indomethacin, Dowex (AG 50
WX4, 200 to 400 mesh), and alumina were purchased from Sigma Chemical
Company. All other chemicals were of the highest purity
commercially available.
Cell Culture
Vascular SMCs
Rat superior mesenteric artery SMCs were isolated and cultured
as previously described.24 Briefly, superior
mesenteric arteries of male Sprague-Dawley rats weighing between 150
and 175 g (Charles River Labs, Wilmington, Mass) were stripped of
fat and connective tissue and digested in minimal essential medium
containing 0.7 mg/mL collagenase (type IA, Sigma), 0.25
mg/mL elastase (type III, Sigma), 0.4 mg/mL soybean trypsin
inhibitor, and 1 mg/mL bovine serum albumin for 60
minutes at 37°C. Dissociated vascular SMCs were seeded into
conventional plastic tissue-culture plates (Falcon) and cultured in
RPMI 1640 medium supplemented with 10% heat-inactivated
fetal bovine serum, plus 100 U/mL penicillin and 100 µg/mL
streptomycin in a humidified atmosphere of 5%
CO2, 95% air. Cells were routinely subcultured
after treatment for 10 minutes with 0.125% trypsin-EDTA at 37°C.
Cells between passages 5 and 9 were used in either monocultures or
cocultures as described below.
Vascular ECs
Bovine aortic ECs (ECs), repository No. AG07680B, were obtained
from the NIA Cell Culture Repository, Coriell Institute for Medical
Research. These cells tested positive for the EC-specific von
Willebrand factor and angiotensin-1 converting
enzyme activity. They tested negative for
-smooth muscle actin. ECs
were maintained under the same conditions as the SMCs above. ECs were
used in cocultures, as described below, between passage 12 and 15.
Perfused Transcapillary Cultures
Cocultures of SMCs and ECs were established essentially as
described in detail previously.23 The CELLMAX
QUAD Artificial Capillary Cell Culture System (Cellco, Inc) was used.
This apparatus was maintained in a standard
CO2 incubator and consisted of an enclosed bundle
of 150 semipermeable, Pronectin-Fcoated polyethylene capillaries
("bioreactor," capillary length 9.6 cm; internal diameter 330
µmol/L; wall thickness 50 µmol/L; pore size 0.3 µmol/L;
extracapillary surface area 164 cm2; lumenal
surface area 124 cm2) through which media from a
reservoir is pumped in a pulsatile fashion, at a chosen flow rate, via
silicone rubber tubing (Fig 1
). By
altering the flow rate, a shear stress range of 0.05 to 15
dyne/cm2 can be achieved in this
system.23
|
Seeding of SMCs and ECs
SMCs (
3.2x107 cells) in RPMI 1640
supplemented with 10% fetal bovine serum and antibiotics were first
seeded into the extracapillary space via the side ports. The SMCs were
allowed to establish themselves in multilayers on the outer surface of
the capillaries for 14 to 17 days. After this period, ECs
(
3x107 cells) were seeded into the lumenal
spaces of the capillary bundle as detailed
previously.23 In some cases, the addition of ECs
to the bioreactor was omitted, thus resulting in monocultured SMCs.
The experimental protocol followed is shown diagrammatically in Fig 1
.
A series of perfused transcapillary cultures was examined
in parallel. The SMC/EC cocultures or the SMC moncultures were
designated as either "low flow" or "high flow." The low-flow
group was exposed to a constant flow rate of 2 mL/min throughout the
experiment, corresponding to a shear stress of 0.5
dyne/cm2. The high-flow group was exposed to
stepwise increases in flow up to 44 mL/min, maintained for 72 hours,
corresponding to a shear stress of 15 dyne/cm2.
Where indicated, high-flow cocultures were treated with L-NAME
(100µmol/L) or indomethacin (10 µmol/L)
throughout the last 72-hour period.
Cell Harvest
At the end of the experimental period, SMCs and ECs were
separately harvested, without trypsin, essentially as described
previously.23 Briefly, ECs were first removed via
the end ports by repeated back flushing with Hanks' balanced salts
solution. The cartridge was cut open using a pipe cutter to access the
SMCs. In this way, separate, pure populations of cells could be
obtained for further analysis.
Particulate Fraction Preparation
Harvested SMCs and ECs were pelleted by low-speed
centrifugation. The cell pellet was resuspended in 3 mL
buffer A (50 mmol/L Tris-HCl, 1 mmol/L EDTA, 0.05%
bacitracin, protease inhibitor cocktail
[Boehringer], pH 7.4), sonicated, and centrifuged at
30 000g for 30 minutes at 4°C. The resulting pellet was
resuspended in buffer A at a concentration of >1 mg/mL and stored at
-70°C. Protein was measured by the method of
Bradford25 using bovine serum albumin as
a standard.
NOS Activity
NOS activity, in particulate fractions prepared from ECs and
SMCs, was measured by determining the conversion of
L-[14C]arginine to
L-[14C]citrulline essentially based
on a method of Bredt and Snyder26 and described
in detail previously.27
PGI2 Measurement by Radioimmunoassay
The stable metabolite of PGI2,
6-keto-PGF1
, was determined in samples of
perfusate from the cocultures by direct radioimmunoassay, using
standard techniques and as described in detail
previously.28 Antisera used for
6-keto-PGF1
had a cross-reactivity of <0.1%
for other common prostaglandins. Values are expressed as
picograms 6-keto-PGF1
per milliliter
perfusate per minute.
Western Blotting
Membrane proteins (15 to 40 µg per lane) were separated on a
10% SDS-polyacrylamide gel as described
previously.29 After SDS-polyacrylamide
gel electrophoresis, the separated proteins were electrophoretically
transferred to nitrocellulose membranes (Hybond-C, Amersham) using a
transphor electroblotter unit (Hoefer Scientific Instruments) at 100 V
for 2 hours. After transfer, the membranes were incubated for 2 hours
in blocking solution containing 50 mmol/L Tris base (pH 7.6),
4 mmol/L MgCl2, and 14 mmol/L NaCl
(TBS) supplemented with 5% nonfat dry milk, 0.1% Tween 20 and 2 mg/mL
sodium azide. The membranes were then washed twice three times for 5
minutes each with TBS containing 0.1% (vol/vol) Tween 20 and 2%
(vol/vol) NP-40. The membranes were incubated with the specific
antisera in TBS-Tween 20, 0.02% (wt/vol) for 1 hour at room
temperature with gentle rocking. After washing the blots three times
for 10 minutes, they were incubated with the secondary antibody
solution (horseradish peroxidase conjugated), diluted 1:5000 in
TBS-Tween 20, for 40 minutes at room temperature with gentle agitation.
The blots were finally washed three times for 10 minutes each before
they were processed using the ECL detection system (Amersham), as
described by the manufacturer. Blots were then covered in cellophane
and exposed to Hyperfilm-ECL (Amersham) for 15 to 30 seconds. Equal
protein loading was confirmed by India ink staining of protein in each
lane of the same blot. The signal intensity (integral volume) of the
appropriate bands on the autoradiogram was
analyzed using a Personal Densitometer (Molecular Dynamics) and
the Imagequant software package (Biosoft).
Adenylyl Cyclase Assay
Adenylyl cyclase activity was assessed by measuring the
conversion of [32P]ATP to
[32P]cAMP, as previously
described.29 Samples (150 µl) routinely
contained
50 µg protein, 1 mmol/L ATP, 0.5 µCi
[32P]ATP, 0.4 mg/mL theophylline, 2.2 mg/mL
creatine phosphate, 0.2 mg/mL creatine phosphokinase, 10 µmol/L
GTP, and 4 mmol/L MgCl2 in TME buffer
(50 mmol/L Tris-HCl, 2 mmol/L MgCl2,
1 mmol/L EDTA, pH 7.4). Assays were ended after 20 minutes at
37°C by addition of 100 µL stopping solution (10 mmol/L
Tris-HCl, 2% SDS, 2 mg/mL ATP, and 0.5 mg/mL cAMP, pH 7.5). The
[32P]cAMP formed was separated from the
[32P]ATP by sequential
chromatography on Dowex and neutral alumina.
Chromatographic yields were 75% to 90%. Specific
activities were expressed as picomoles cAMP formed per milligram of
protein per minute.
Pertussis ToxinCatalyzed ADP Ribosylation
G-protein substrates of pertussis toxin were assayed using
pertussis toxin-catalyzed incorporation of
[32P]ADP-ribose from
[32P]NAD, as previously
described.29 Membranes (40 to 60 µg) were
resuspended in 100 µL of 100 mmol/L Tris-HCl (pH 8.0),
containing 5 mmol/L DTT, 10 mmol/L thymidine, 6 mmol/L
MgCl2, 2 mmol/L GTP, 2.5 mmol/L ATP,
and 10 µmol/L [32P]NAD. Pertussis toxin
(100 µg/mL) was activated by prior incubation in 50
mmol/L HEPES (pH 8.0), containing 20 mmol/L DTT, 0.125% SDS, and
0.1 mg/mL BSA for 30 minutes at room temperature. After addition of
activated pertussis toxin (20 µg/mL), the membrane
preparations were incubated for 90 minutes at 30°C. The ADP
ribosylation reactions were stopped by centrifugation
at 15 000g for 3 minutes and the pellet was resuspended in
SDS-sample buffer containing 62.5 mmol/L Tris-HCl (pH 6.8), 2%
SDS, 10% (vol/vol) glycerol, and 5% (vol/vol) ß-mercaptoethanol.
The samples were boiled for 10 minutes before being resolved on a 10%
SDS-polyacrylamide gel. Gels were dried on cellophane and
exposed to Kodak XAR-5 film with an intensifying screen at -70°C for
1 to 3 days.
GTPase Assay
A modification of the method described by Weber and
Macleod30 was used to measure release of
[32P]i from
[
32P] GTP. The assay system contained
[
32P] GTP (
50 000 cpm), 5 mmol/L
MgCl2, 0.1 mmol/L EGTA, 50 µmol/L
NaCl, 4 mmol/L creatine phosphate, 5 U phosphocreatine kinase,
0.1 mmol/L ATP, 0.5 µmol/L GTP, 1 mmol/L DTT, 33
mmol/L Tris-HCl, pH 7.4, and 10 to 15µg of membrane protein in a
total volume of 150 µL. The assay was initiated by addition of
membranes to the reaction mixture and incubating for 15 minutes at
22°C in the absence or presence of norepinephrine
(10 µmol/L). The reaction was terminated with 500 µL of
ice-cold 5% activated charcoal in 20 mmol/L phosphoric
acid, and the mixture was centrifuged for 10 minutes at
12,000g at 4°C. The liberated
[32P]i was determined by
counting the supernatant for 1 minute in a liquid scintillation
counter. High affinity GTPase activity was calculated as the difference
between total and nonspecific hydrolysis (determined in the presence of
100µmol/L GTP).
Statistics
The data shown are the mean±SEM. Statistical significance was
estimated using the following analysis: Unpaired Student's
t test for comparison of two groups; Wilcoxon signed
rank test for the densitometric data. A value of P<.05 was
considered significant.
| Results |
|---|
|
|
|---|
)
15
dyne/cm2) exhibited a significant increase,
compared with low flow (2 mL/min, shear stress
0.5
dyne/cm2), in eNOS from 1.75±0.3 to 3.85±0.5
pmol [14C]citrulline per minute per milligram,
n=7, P<.05. Treatment of cocultures with 100 µmol/L
L-NAME significantly inhibited the flow-induced increases in eNOS
activity (60±5%, P<.05, n=3). Similarly,
6-keto-PGF1
levels were significantly elevated
in the conditioned media under high-flow conditions compared with low
flow (2.20±0.3 to 3.7±0.7 pg 6-keto-PGF1
per
milliliter perfusate per minute, P<.05). In
addition, pretreatment of the EC/SMC cocultures with 10 µmol/L
indomethacin, a COX inhibitor,
significantly decreased the levels of
6-keto-PGF1
in conditioned media under
high-flow conditions (3.7±0.7 to 0.69±0.1 pg
6-keto-PGF1
per milliliter perfusate
per minute, P<.05, n=3).
Effect of Increased Flow on Cocultured EC G-Protein
Expression
Using Western Blot analysis, ECs cocultured with
SMCs expressed Gi
12,
Gi
3, G
q, and Gs
proteins under both
low-flow (2 mL/min, shear stress
0.5 dyne/cm2)
and high-flow (44 mL/min, shear stress
15
dyne/cm2) conditions. In addition, the detection
of these antigens was linear with respect to protein concentrations for
each G-protein examined (data not shown). In cocultured ECs exposed to
high-flow conditions, Gi
3 protein expression
was significantly enhanced compared with cocultured ECs exposed to
low-flow conditions (Fig 2
). Cumulative
densitometric analysis of Gi
3 protein
expression in ECs exposed to high flow demonstrated a 41±2.9%
increase compared with low flow. However, inhibition of eNOS or COX
activity with L-NAME (100 µmol/L) and
indomethacin (10 µmol/L), respectively, failed
to reverse the flow-induced increase in Gi
3
protein expression (Fig 3
). The
specificity of the flow-induced increase in
Gi
3 protein expression was apparent because
there was no significant effect of increased flow on cocultured ECs
Gi
12, G
q, or Gs
expression (Fig 4a
, 4b
, and 4c
).
|
|
|
Effect of Increased Flow on Cocultured SMC G-Protein
Expression
The effect of increased flow on SMC G-protein expression was
determined in SMCs that had been cultured either in the presence
(cocultures) or absence (monocultures) of ECs. In this way it was
possible to assess the role, if any, of the endothelium
in mediating a change in SMC G-protein expression. Using Western Blot
analysis, SMCs cocultured with ECs and cultured alone expressed
Gi
12, Gi
3, G
q, and Gs
proteins
under both low-flow (2 mL/min, shear stress
0.5
dyne/cm2) and high-flow (44 mL/min, shear stress
15 dyne/cm2) conditions. In addition, the
detection of these antigens was linear with respect to SMC protein
concentrations for each G-protein examined (data not shown).
Gi
12 expression was significantly decreased
(57±5%) in cocultured SMCs exposed to high flow compared with
cocultured SMCs exposed to low flow (Fig 5
). This appeared to be an
endothelium-dependent effect, as there was no effect of
flow on Gi
12 in SMCs cultured in the absence
of ECs (Fig 6
). In addition, the
flow-induced decrease in cocultured SMC Gi
12
expression was completely reversed by indomethacin
(10 µmol/L), whereas L-NAME (100 µmol/L) had no effect
(Fig 6
). There was no effect of flow on Gi
3, G
q, or Gs
expression in either cocultured SMCs or SMCs cultured alone in the
absence of ECs (Fig 7
).
|
|
|
Effect of Increased Flow on Cocultured EC and SMC Adenylyl Cyclase
Activity, Pertussis ToxinCatalyzed ADP-Dependent Ribosylation of
Gi
Substrates, and Agonist-Stimulated GTPase Activity
To determine whether flow-induced differential changes in
endothelial and vascular SMC G-protein expression
correlated with changes in (1) the signaling capacity of these cells
and/or (2) G-protein functionality, we measured adenylyl cyclase
activity, pertussis toxincatalyzed NAD-dependent ADP ribosylation,
and agonist-stimulated GTPase activity, respectively, in both cell
types. Basal adenylyl cyclase activity, as well as that stimulated by
GTP
S (a nonhydrolyzable guanine nucleotide analogue) and
forskolin (a diterpine derivative), was measured in ECs and SMCs
cocultured under either low- or high-flow conditions. Adenylyl cyclase
activities in membranes prepared from cocultured ECs and SMCs were
linear with respect to increasing concentrations of protein (5 to 100
µg) (data not shown).
In cocultured ECs, basal adenylyl cyclase activity was
significantly greater in membranes prepared from ECs exposed to
high-flow conditions compared with those under low-flow conditions
(15.57±0.77 versus 6.8±0.27 pmol cAMP per milligram protein per
minute). Similarly, GTP
S (10 µmol/L)- and forskolin (50
µmol/L)-stimulated adenylyl cyclase activity was significantly
greater in membranes prepared from ECs exposed to high-flow conditions
(Fig 8
). Similarly, in cocultured SMCs,
basal adenylyl cyclase activity was significantly greater in SMC
membranes prepared from cocultured SMCs exposed to high-flow conditions
compared with those under low-flow conditions (31.0±3.4 versus
15.3±2.0 pmol cAMP per milligram per minute). Moreover, GTP
S and
forskolin-stimulated adenylyl cyclase activity was significantly
greater in SMC membranes prepared from SMCs exposed to high-flow
conditions (Fig 8
).
|
We further examined the functionality of the flow-induced changes in
G-protein expression in cocultured cells exposed to high flow by
determining pertussis toxincatalyzed ADP-dependent ribosylation of
Gi
substrates. Pertussis toxin catalyzed the incorporation of
[32P]ADP-ribose into one major peptide band
(
40 kD) in both low-flow and high-flow cultured cells, a protein
that comigrated with Gi
proteins immunodetected using specific
antibodies for Gi
proteins (data not shown). The ribosylation was
linear over a range of 10 to 100 µg of membrane protein (data not
shown). Pertussis toxincatalyzed ribosylation of Gi
substrates was
significantly increased in cocultured EC membranes but significantly
decreased in SMC membranes prepared from cells exposed to high-flow
conditions, respectively (Fig 9
).
|
Receptor G-protein coupling in both ECs and SMCs exposed to low- and
high-flow conditions was determined by measuring agonist-stimulated
GTPase activity in membranes prepared from these cells. The release of
[32P]i from
[
32P]GTP by cocultured EC and SMC membranes
was determined in the absence and presence of
norepinephrine (10 µmol/L). There was no significant
difference in basal EC GTPase activity between low- and high-flow
groups: 26.16±1.2 versus 23.1±2.0 pmol
[32P]i per milligram
protein per minute (n=3). Agonist-stimulated GTPase activity was
significantly increased in high-flow EC membranes compared with the
low-flow group (Fig 10
). In contrast,
in SMC membranes, basal GTPase activity was significantly greater in
the high-flow group; 8.24±3.9 versus 17.83±2.1 pmol
[32P]i per milligram
protein per minute (n=3). However, in cocultured SMCs there was a
significant decrease in agonist-stimulated GTPase activity in high-flow
membranes (Fig 10
).
|
| Discussion |
|---|
|
|
|---|
ECs cocultured with SMCs significantly increased their expression of a
pertussis toxinsensitive Gi
3 protein after
exposure to high flow. The flow-induced changes in EC G-protein
expression correlated with changes in (1) the signaling capacity of
these cells (ie, enhanced NO and PGI2
production) and (2) the functionality of the G-protein, since
agonist-stimulated GTPase activity and pertussis toxincatalyzed
NAD-dependent ribosylation of Gi
substrates were significantly
increased in these cells. As a consequence of these observations,
decreased basal adenylyl cyclase activity might be anticipated if these
proteins are coupled in part to this enzyme. In contrast, enhanced
basal and G-proteinstimulated adenylyl cyclase activity was observed,
an effect previously reported for monocultures of ECs exposed to cyclic
stretch.11 These data are consistent with
a flow-mediated increase in EC adenylyl cyclase activity that appears
independent of changes in either Gs
or Gi
protein expression.
Adenylyl cyclase isoforms are regulated at many different levels
including
- and ß
-subunits,35 any of
which could contribute to the enhanced activity in ECs exposed to high
flow. Therefore, the enhanced basal and stimulated activity observed in
ECs may reflect enhanced stimulatory Gs
protein activity,
ß
-subunit activity, and/or enhanced intrinsic activity of the
adenylyl cyclase enzyme itself in ECs exposed to high flow. Whether
these changes or other pathways that modulate adenylyl cyclase activity
occur in ECs exposed to high flow requires further investigation.
The role of increased EC Gi
3 protein
expression and subsequent cellular signaling remains unclear, but it
may be involved in the sustained flow-induced production of NO
and/or PGI2. While previous studies have reported
that shear stressinduced changes in NO and PGI2
production are both pertussis toxin sensitive and
insensitive,18 32 depending on the length of
exposure to flow, preliminary experiments from our laboratory using
cocultured ECs suggest that pertussis toxin inhibits flow-induced eNOS
activity after a 2-hour exposure to high flow. Alternatively, the
changes in Gi
3 protein expression and activity
may underlie an enhanced sensitivity of the sheared EC to
endothelial agonist (ATP, thrombin, endothelin, and
-adrenergic) receptor Gi-protein coupled activation of NOS and COX
activity.1 36 37 38 This occurs in mesenteric
resistance vessels exposed to chronic increases in blood flow in vivo
in that eNOS activity is enhanced,27 39 Gi
protein expression and activity is increased,29
and endothelial-dependent Gi
-proteininduced
relaxation is greater in vitro.40 In the
present study, norepinephrine, which activates
eNOS by binding to
2-adrenergic receptors on
ECs,41 stimulated GTPase activity (an index
of receptor G-protein coupling), to a greater extent in ECs exposed to
high flow, confirming an enhanced signaling capacity of these
cells.
Few studies have examined the chronic effects of flow-induced
changes in ECs on signaling within the underlying vascular smooth
muscle. Our study is the first in vitro study to demonstrate that flow
induces signaling changes in ECs that subsequently impact on the
expression of Gi proteins in cocultured vascular SMCs. The EC
dependency of this effect was evident in monocultured smooth muscle,
where G-protein expression was unaltered. The flow-induced change in
SMC Gi
12 protein expression correlated with
a significant decrease in pertussis toxincatalyzed ADP ribosylation
of Gi
substrates and agonist-stimulated GTPase activity and enhanced
basal and stimulated adenylyl cyclase activity. Since flow increased
the production of NO and PGI2 from ECs,
there was the possibility of the involvement of either
endothelium-derived vasoactive substance in mediating
the changes in vascular smooth muscle Gi
12
expression. Indeed, exogenous NO has recently been shown to decrease
the expression of both Go
and pertussis toxinsensitive G-proteins
in peritoneal macrophages, vascular SMCs, and neuroblastoma
cells, respectively.42 43 44 Inhibition of COX
activity with indomethacin resulted in a significant
decrease in 6-keto-PGF1
levels in the
conditioned media concomitant with a complete reversal of the
flow-induced endothelium-dependent regulation of
vascular smooth muscle Gi
12 protein
expression. In contrast, eNOS inhibition with L-NAME failed to reverse
the decrease in vascular smooth muscle Gi
12
protein expression despite decreasing eNOS activity and therefore
subsequent NO production from ECs. Whether
PGI2 or another
endothelium-derived COX product is responsible for
the observed decrease in smooth muscle Gi
12
protein expression remains uncertain.
The consequences of the endothelium-dependent,
indomethacin-sensitive decrease in SMC
Gi
12 protein expression and subsequent
altered cellular signaling remains unclear. Decreased
Gi
12 protein expression on vascular SMCs may
serve to adapt local vascular tone to the modifications of increased
flow. In fact, the role of pertussis toxinsensitive G-proteins in
signaling pathways that regulate vascular tone have been well
documented.45 Continuous release of NO and
PGI2 from ECs exposed chronically to high flow
may act to alter neurogenic and myogenic vasoconstriction directly or
indirectly by modulating pressor hormone G-protein
signaling.46 Furthermore, altered
Gi
12 protein expression on SMCs due to
sustained flow may contribute to the control of vascular cell
proliferation. Several studies have demonstrated the importance of
pertussis toxinsensitive G-proteins in signaling pathways that
mediate vascular remodeling and mitogenesis,1 2 3
including the mitogen-activated protein kinase
pathways.47 48
The present study demonstrates that there exists potentially
important mechanisms of vessel diameter modulation involving
endothelial and SMC Gi-protein expression regulation in
response to chronic changes in flow. These changes in Gi-protein
expression occur when flow is increased well within the
physiological range of shear stress that is found
along the vascular tree.1 2 3 Moreover, they
correlate well with characterized physiological
responses; eNOS activity and PGI2 release in ECs,
and reflect significant changes in the signaling capacity of both ECs
and SMCs. In conclusion, changes in vascular cell Gi
-protein
expression after chronic increases in flow may represent an
important pathway by which vascular cells adapt to changes in blood
flow.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
| Footnotes |
|---|
Received June 4, 1997; accepted September 17, 1997.
| References |
|---|
|
|
|---|
2. Osol G. Mechanotransduction by vascular smooth muscle. J Vasc Res. 1995;32:275292.[Medline] [Order article via Infotrieve]
3. Skalak TC, Price RJ. The role of mechanical stresses in microvascular remodeling. Microcirculation. 1996;3:143165.[Medline] [Order article via Infotrieve]
4.
Frangos JA, Eskin SG, McIntire LV, Ives CL. Flow
effects on prostacyclin production by cultured human
endothelial cells. Science. 1985;227:14771479.
5.
Ranjan V, Xiao Z, Diamond SL. Constitutive NOS
expression in cultured endothelial cells is elevated by
fluid shear stress. Am J Physiol. 1995;269:H550H555.
6.
Kuchan MJ, Frangos JA. Shear stress regulates
endothelin-1 release via protein kinase C and cGMP in cultured
endothelial cells. Am J Physiol. 1993;264:H150H156.
7.
Lan Q, Mercurius KO, Davies PF. Stimulation of
transcription factors NF
B and AP-1 in
endothelial cells subjected to shear stress.
Biochem Biophys Res Commun. 1994;201:950956.[Medline]
[Order article via Infotrieve]
8. Awolesi MA, Sessa WC, Sumpio BE. Cyclic strain upregulates nitric oxide synthase in cultured bovine aortic endothelial cells. J Clin Invest. 1995;96:14491454.
9.
Cheng JJ, Wung BS, Chao WJ, Wang DL. Cyclic strain
enhances adhesion of monocytes to endothelial cells by
increasing intracellular adhesion molecule-1 expression.
Hypertension. 1996;28:386391.
10. Cheng JJ, Chao WJ, Wung BS, Wang DL. Cyclic strain-induced plasminogen activator inhibitor-1 (PAI-1) release from endothelial cells involves reactive oxygen species. Biochem Biophys Res Commun. 1996;225:100105.[Medline] [Order article via Infotrieve]
11. Letsou GV, Rosales O, Maitz S, Vogt A, Sumpio BE. Stimulation of adenylate cyclase activity in cultured endothelial cells subjected to cyclic stretch. J Cardiovasc Surg. 1990;31:634639.[Medline] [Order article via Infotrieve]
12. Manolopoulos VG, Lelkes PL. Cyclic strain and forskolin differentially induce cAMP production in phenotypically diverse endothelial cells. Biochem Biophys Res Commun. 1993;191:13791385.[Medline] [Order article via Infotrieve]
13.
Rosales OR, Sumpio BE. Changes in cyclic strain
increase inositol triphosphate and diacylglycerol in
endothelial cells. Am J Physiol. 1992;262:C956C962.
14. Gorfien SF, Howard PS, Myers JC, Macarak EJ. Cyclic biaxial strain of pulmonary artery endothelial cells causes an increase in cell layer-associated fibronectin. Am J Respir Cell Mol Biol. 1990;3:421429.
15. Wilson E, Sudhir K, Ives HE. Mechanical strain of rat vascular smooth muscle cells is sensed by specific extracellular matrix/integrin interactions. J Clin Invest. 1995;96:23642372.
16. Levitzki A, Bar-Sinai A. The regulation of adenylyl cyclase by receptor G proteins. Pharmacol Ther. 1991;50:271283.[Medline] [Order article via Infotrieve]
17. Helmreich EJ, Hofmann KP. Structure and function of proteins in G-protein coupled signal transfer. Biochim Biophys Acta. 1996;1286:285322.[Medline] [Order article via Infotrieve]
18. Berthiaume F, Frangos JA. Flow-induced prostacyclin production is mediated by a pertussis toxin-sensitive G-protein. FEBS Lett. 1992;308:277279.[Medline] [Order article via Infotrieve]
19.
Ohno M, Gibbons GH, Dzau VJ, Cooke JD. Shear stress
elevated endothelial cGMP: role of a potassium channel
and G-protein coupling. Circulation. 1993;88:193197.
20. Cooke JP, Rossitch E, Ardon NA, Loscalzo J, Dzau VJ. Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest. 1991;88:16631671.
21. Meij JT. Regulation of G protein function: implications for heart disease. Mol Cell Biochem. 1996;157:3138.[Medline] [Order article via Infotrieve]
22. Johnson MD, Friedman E. G proteins in cardiovascular function and dysfunction. Biochem Pharmacol. 1993;45:23652372.[Medline] [Order article via Infotrieve]
23. Redmond EM, Cahill PA, Sitzmann JV. Perfused transcapillary smooth muscle cells and endothelial cell coculture: a novel in vitro model. In Vitro Cell Dev Biol.. 1995;31:601609.
24. Redmond EM, Cahill PA, Hodges R, Zhang S, Sitzmann JV. Regulation of endothelin receptors by nitric oxide in rat vascular smooth muscle cells. J Cell Physiol. 1996;166:469479.[Medline] [Order article via Infotrieve]
25. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248254.[Medline] [Order article via Infotrieve]
26.
Bredt DS, Snyder SH. Isolation of nitric oxide
synthase, a calmodulin-requiring enzyme. Proc Natl
Acad Sci U S A. 1990;87:682685.
27. Cahill PA, Redmond EM, Foster C, Gingalewski C, Wu Y, Sitzmann JV. Enhanced nitric oxide synthase activity in portal hypertensive rabbits. Hepatology. 1995;22:598606.[Medline] [Order article via Infotrieve]
28.
Redmond EM, Cherian M, Wetzel RC. 17-Beta estradiol
inhibits flow- and acute hypoxiainduced prostacyclin release
from endocardial endothelial cells.
Circulation. 1994;90:25192524.
29. Cahill PA, Wu Y, Sitzmann JV. Altered adenylyl cyclase activities and G-protein abnormalities in portal hypertensive rabbits. J Clin Invest. 1994;93:26912700.
30. Weber LP, Macleod KM. Noradrenaline stimulation of high-affinity GTPase activity in membranes from rat aorta and caudal artery. Biochem Pharmacol. 1996;52:677684.[Medline] [Order article via Infotrieve]
31.
Gudi SR, Clark CB, Frangos JA. Fluid flow rapidly
activates G proteins in human endothelial
cells: involvement of G proteins in mechanochemical signal
transduction. Circ Res. 1996;79:834839.
32.
Kuchan MJ, Frangos JA. Role of G-proteins in shear
mediated nitric oxide production by endothelial
cells. Am J Physiol. 1994;267:C753C758.
33.
Ishida T, Peterson P, Kovach ML, Berk BC. MAPK kinase
activation by flow in endothelial cells: role of
ß1-integrin and tyrosine kinases. Circ Res. 1996;79:310316.
34. Takahashi M, Berk BC. Mitogen-activated protein kinase (ERK1/2) activation by shear stress and adhesion in endothelial cells: essential role for a herbimycin-sensitive kinase. J Clin Invest. 1996;98:26232631.[Medline] [Order article via Infotrieve]
35.
Ishikawa Y, Homcy CJ. The adenylyl cyclases as
integrators of transmembrane signal transduction. Circ Res. 1997;80:297304.
36.
Liao JK, Homcy CJ. Specific receptorguanine
nucleotide binding protein interaction mediates the release
of endothelium-derived relaxing factor. Circ
Res. 1992;70:10181026.
37.
Flavahan NA, Shimonoka H, Vanhoutte PM. Pertussis toxin
inhibits endothelium-dependent relaxations evoked by
certain endothelial activators in porcine
coronary arteries. J Physiol. 1989;408:549561.
38. Flavahan NA, Vanhoutte PM. G-protein and endothelial response. Blood Vessels. 1990;27:218229.[Medline] [Order article via Infotrieve]
39. Cahill PA, Redmond EM, Hodges R, Zhang S, Sitzmann JV. Increased endothelial nitric oxide synthase activity within the hyperemic vessels of portal hypertensive rats. J Hepatol. 1996;25:370378.[Medline] [Order article via Infotrieve]
40. Hou M-C, Cahill PA, Zhang S, Redmond EM, Sitzmann JV. Enhanced G-protein-induced relaxation in portal hypertensive rats: role of nitric oxide. Hepatology. 1997;26:2733.[Medline] [Order article via Infotrieve]
41.
Bryan RM, Steenberg ML, Eichler MY, Johnson TD,
Swafford MW, Suresh MS. Permissive role of NO in
2
adrenoreceptor dilations in rat cerebral arteries.
Am J Physiol. 1995;269:H11711174.
42. Lander HM, Sehajpal PK, Novogrodsky A. Nitric oxide signaling: possible role for G-proteins. J Immunol. 1993;151:71827187.[Abstract]
43. Cahill PA, Redmond EM, Sitzmann JV. Regulation of G-protein expression by nitric oxide in rat vascular smooth muscle cells. FASEB J. 1995;9:A672. Abstract.
44. Hess DT, Lin LH, Freeman JH, Norden JJ. Modification of cysteine residues with Go and other neuronal proteins by exposure to nitric oxide. Neuropharmacology. 1994;33:12831292.[Medline] [Order article via Infotrieve]
45. Abebe W, Edwards JD, Agrawal DK. G-proteins in rat blood vessels: assessment of functional involvement. Gen Pharmacol. 1995;26:7583.[Medline] [Order article via Infotrieve]
46. Redmond EM, Cahill PA, Sitzmann JV. Flow-mediated regulation of endothelin receptors in cocultured vascular smooth muscle cells: an endothelium-dependent effect. J Vasc Res. 1997. In press.
47. Page C, Doubell AF. Mitogen-activated protein kinase (MAPK) in cardiac tissues. Mol Cell Biochem. 1996;157:4957.[Medline] [Order article via Infotrieve]
48.
Tseng H, Peterson TE, Berk BC. Fluid shear stress
stimulates mitogen-activated protein kinase in
endothelial cells. Circ Res. 1995;77:869878.
This article has been cited by other articles:
![]() |
J.-J. Chiu, L.-J. Chen, S.-F. Chang, P.-L. Lee, C.-I Lee, M.-C. Tsai, D.-Y. Lee, H.-P. Hsieh, S. Usami, and S. Chien Shear Stress Inhibits Smooth Muscle Cell-Induced Inflammatory Gene Expression in Endothelial Cells: Role of NF-{kappa}B Arterioscler Thromb Vasc Biol, May 1, 2005; 25(5): 963 - 969. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Walshe, G. Ferguson, P. Connell, C. O'Brien, and P. A. Cahill Pulsatile Flow Increases the Expression of eNOS, ET-1, and Prostacyclin in a Novel In Vitro Coculture Model of the Retinal Vasculature Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 375 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Miyakawa, M. de Lourdes Junqueira, and J. E. Krieger Identification of two novel shear stress responsive elements in rat angiotensin I converting enzyme promoter Physiol Genomics, April 13, 2004; 17(2): 107 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Cotter, N. v. O. Sweeney, P. M. Coen, Y. A. Birney, M. J. Glucksman, P. A. Cahill, and P. M. Cummins Regulation of Endopeptidases EC3.4.24.15 and EC3.4.24.16 in Vascular Endothelial Cells by Cyclic Strain: Role of Gi Protein Signaling Arterioscler Thromb Vasc Biol, March 1, 2004; 24(3): 457 - 463. [Abstract] [Full Text] |
||||
![]() |
J.-J. Chiu, L.-J. Chen, P.-L. Lee, C.-I Lee, L.-W. Lo, S. Usami, and S. Chien Shear stress inhibits adhesion molecule expression in vascular endothelial cells induced by coculture with smooth muscle cells Blood, April 1, 2003; 101(7): 2667 - 2674. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Cullen, S. Sayeed, R. S. Sawai, N. G. Theodorakis, P. A. Cahill, J. V. Sitzmann, and E. M. Redmond Pulsatile Flow-Induced Angiogenesis: Role of Gi Subunits Arterioscler Thromb Vasc Biol, October 1, 2002; 22(10): 1610 - 1616. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Imamura, S. Biro, T. Kihara, S. Yoshifuku, K. Takasaki, Y. Otsuji, S. Minagoe, Y. Toyama, and C. Tei Repeated thermal therapy improves impaired vascular endothelial function in patients with coronary risk factors J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1083 - 1088. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Garcia-Cardena, J. Comander, K. R. Anderson, B. R. Blackman, and M. A. Gimbrone Jr. Inaugural Article: Biomechanical activation of vascular endothelium as a determinant of its functional phenotype PNAS, April 10, 2001; 98(8): 4478 - 4485. [Abstract] [Full Text] [PDF] |
||||
![]() |
D B. Sanders, T. Kelley, and D. Larson The role of nitric oxide synthase/nitric oxide in vascular smooth muscle control Perfusion, March 1, 2000; 15(2): 97 - 104. [Abstract] [PDF] |
||||
![]() |
T. V. Lewis, A. M. Dart, J. P. F. Chin-Dusting, and B. A. Kingwell Exercise Training Increases Basal Nitric Oxide Production From the Forearm in Hypercholesterolemic Patients Arterioscler Thromb Vasc Biol, November 1, 1999; 19(11): 2782 - 2787. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Li, Y. Hu, M. Mayr, and Q. Xu Cyclic Strain Stress-induced Mitogen-activated Protein Kinase (MAPK) Phosphatase 1 Expression in Vascular Smooth Muscle Cells Is Regulated by Ras/Rac-MAPK Pathways J. Biol. Chem., September 3, 1999; 274(36): 25273 - 25280. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |